Joint Symposium ESMO-EACR: How mouse models can help develop better targeted therapies
From patient derived xenografts to the development of clinical trials: the HERACLES study in HER2-amplified metastatic colorectal cancer
Date
07 Oct 2016Session
Joint Symposium ESMO-EACR: How mouse models can help develop better targeted therapiesPresenters
Salvatore SienaAuthors
S. SienaAuthor affiliations
- Niguarda Cancer Center, Grande Ospedale Metroploitano Niguarda, 20162 - Milan/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Modelling thoracic cancers in the mouse
Presenter: Anton Berns
Session: Joint Symposium ESMO-EACR: How mouse models can help develop better targeted therapies
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Presenter: Anton Berns
Session: Joint Symposium ESMO-EACR: How mouse models can help develop better targeted therapies
Resources:
Slides
Webcast